Literature DB >> 15586232

Rabdosia rubescens inhibits breast cancer growth and angiogenesis.

Maryam R Sartippour1, Navindra P Seeram, David Heber, Mary Hardy, Andrew Norris, Qingyi Lu, Liping Zhang, Ming Lu, Jian Yu Rao, Mai N Brooks.   

Abstract

Investigators have shown that PC-SPES is a potent herbal mixture which has often been used by prostate cancer patients. In this study, we examined the inhibitory effects of certain individual components of PC-SPES on the in vitro proliferation of the human breast cancer cells MDA-MB231 and the human umbilical vein endothelial cells (HUVEC). Our data showed that individual components of PC-SPES had varying suppressive effects on cellular proliferation, and that Rabdosia rubescens appeared to be the most potent agent in these assays. Apoptosis was up-regulated by Rabdosia rubescens, as seen in the caspase-9 and TUNEL assays. These effects may be mediated via both the MAPK (mitogen-activated protein kinase) and the Akt kinase pathways. In mouse experiments, the extract from Rabdosia rubescens suppressed breast cancer xenograft size and decreased the tumor vessel density. We conclude that Rabdosia rubescens may potentially be used to treat or prevent breast cancer, and that the extract from this herbal source deserves further studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15586232

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Genomic and in vivo evidence of synergy of a herbal extract compared to its most active ingredient: Rabdosia rubescens vs. oridonin.

Authors:  Angela M Wong; Yanjung Zhang; Kelly Kesler; Max Deng; Lucas Burhenn; David Wang; Aune Moro; Zhaoping Li; David Heber
Journal:  Exp Ther Med       Date:  2010-09-01       Impact factor: 2.447

2.  Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology.

Authors:  Hongwen Cao; Dan Wang; Renjie Gao; Chenggong Li; Yigeng Feng; Lei Chen
Journal:  PeerJ       Date:  2022-06-27       Impact factor: 3.061

3.  Oridonin-induced apoptosis in SW620 human colorectal adenocarcinoma cells.

Authors:  Zhe Ji; Qingjiu Tang; Jinsong Zhang; Yan Yang; Yanfang Liu; Yingjie Pan
Journal:  Oncol Lett       Date:  2011-09-02       Impact factor: 2.967

Review 4.  Discovery and development of natural product oridonin-inspired anticancer agents.

Authors:  Ye Ding; Chunyong Ding; Na Ye; Zhiqing Liu; Eric A Wold; Haiying Chen; Christopher Wild; Qiang Shen; Jia Zhou
Journal:  Eur J Med Chem       Date:  2016-06-13       Impact factor: 6.514

5.  Oridonin induces the apoptosis of metastatic hepatocellular carcinoma cells via a mitochondrial pathway.

Authors:  Min Zhu; Dun Hong; Yanfang Bao; Chen Wang; Weibo Pan
Journal:  Oncol Lett       Date:  2013-08-23       Impact factor: 2.967

6.  Isolation and purification of oridonin from the whole plant of Isodon rubescens by high-speed counter-current chromatography.

Authors:  Fa He; Yuhua Bai; Jing Wang; Jing Wei; Chunyue Yu; Sen Li; Weili Yang; Chenghua Han
Journal:  Molecules       Date:  2011-09-14       Impact factor: 4.411

7.  Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines.

Authors:  Lynn S Adams; Navindra P Seeram; Mary L Hardy; Catherine Carpenter; David Heber
Journal:  Evid Based Complement Alternat Med       Date:  2006-03       Impact factor: 2.629

8.  Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses.

Authors:  Onat Kadioglu; Mohamed Saeed; Victor Kuete; Henry J Greten; Thomas Efferth
Journal:  Front Pharmacol       Date:  2018-04-16       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.